Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaginal and Vulval Inflammatory Disease Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Vaginal Dryness
1.2.3 Vaginal Burning
1.2.4 Vaginal Discharge
1.2.5 Genital Itching
1.2.6 Recurrent Urinary Tract Infections
1.2.7 Urinary Incontinence
1.2.8 Others
1.3 Market by Application
1.3.1 Global Vaginal and Vulval Inflammatory Disease Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacies
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Vaginal and Vulval Inflammatory Disease Treatment Market Perspective (2018-2033)
2.2 Global Vaginal and Vulval Inflammatory Disease Treatment Growth Trends by Region
2.2.1 Vaginal and Vulval Inflammatory Disease Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Vaginal and Vulval Inflammatory Disease Treatment Historic Market Size by Region (2018-2023)
2.2.3 Vaginal and Vulval Inflammatory Disease Treatment Forecasted Market Size by Region (2024-2033)
2.3 Vaginal and Vulval Inflammatory Disease Treatment Market Dynamics
2.3.1 Vaginal and Vulval Inflammatory Disease Treatment Industry Trends
2.3.2 Vaginal and Vulval Inflammatory Disease Treatment Market Drivers
2.3.3 Vaginal and Vulval Inflammatory Disease Treatment Market Challenges
2.3.4 Vaginal and Vulval Inflammatory Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Vaginal and Vulval Inflammatory Disease Treatment by Players
3.1.1 Global Vaginal and Vulval Inflammatory Disease Treatment Revenue by Players (2018-2023)
3.1.2 Global Vaginal and Vulval Inflammatory Disease Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Vaginal and Vulval Inflammatory Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Vaginal and Vulval Inflammatory Disease Treatment, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Vaginal and Vulval Inflammatory Disease Treatment Market Concentration Ratio
3.4.1 Global Vaginal and Vulval Inflammatory Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaginal and Vulval Inflammatory Disease Treatment Revenue in 2022
3.5 Global Key Players of Vaginal and Vulval Inflammatory Disease Treatment Head office and Area Served
3.6 Global Key Players of Vaginal and Vulval Inflammatory Disease Treatment, Product and Application
3.7 Global Key Players of Vaginal and Vulval Inflammatory Disease Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Vaginal and Vulval Inflammatory Disease Treatment Breakdown Data by Type
4.1 Global Vaginal and Vulval Inflammatory Disease Treatment Historic Market Size by Type (2018-2023)
4.2 Global Vaginal and Vulval Inflammatory Disease Treatment Forecasted Market Size by Type (2024-2033)
5 Vaginal and Vulval Inflammatory Disease Treatment Breakdown Data by Application
5.1 Global Vaginal and Vulval Inflammatory Disease Treatment Historic Market Size by Application (2018-2023)
5.2 Global Vaginal and Vulval Inflammatory Disease Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Vaginal and Vulval Inflammatory Disease Treatment Market Size (2018-2033)
6.2 North America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type
6.2.1 North America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2018-2023)
6.2.2 North America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2024-2033)
6.2.3 North America Vaginal and Vulval Inflammatory Disease Treatment Market Share by Type (2018-2033)
6.3 North America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application
6.3.1 North America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2018-2023)
6.3.2 North America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2024-2033)
6.3.3 North America Vaginal and Vulval Inflammatory Disease Treatment Market Share by Application (2018-2033)
6.4 North America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Country
6.4.1 North America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Country (2018-2023)
6.4.3 North America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Vaginal and Vulval Inflammatory Disease Treatment Market Size (2018-2033)
7.2 Europe Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type
7.2.1 Europe Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2018-2023)
7.2.2 Europe Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2024-2033)
7.2.3 Europe Vaginal and Vulval Inflammatory Disease Treatment Market Share by Type (2018-2033)
7.3 Europe Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application
7.3.1 Europe Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2018-2023)
7.3.2 Europe Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2024-2033)
7.3.3 Europe Vaginal and Vulval Inflammatory Disease Treatment Market Share by Application (2018-2033)
7.4 Europe Vaginal and Vulval Inflammatory Disease Treatment Market Size by Country
7.4.1 Europe Vaginal and Vulval Inflammatory Disease Treatment Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Vaginal and Vulval Inflammatory Disease Treatment Market Size by Country (2018-2023)
7.4.3 Europe Vaginal and Vulval Inflammatory Disease Treatment Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Vaginal and Vulval Inflammatory Disease Treatment Market Size (2018-2033)
8.2 China Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type
8.2.1 China Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2018-2023)
8.2.2 China Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2024-2033)
8.2.3 China Vaginal and Vulval Inflammatory Disease Treatment Market Share by Type (2018-2033)
8.3 China Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application
8.3.1 China Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2018-2023)
8.3.2 China Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2024-2033)
8.3.3 China Vaginal and Vulval Inflammatory Disease Treatment Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Vaginal and Vulval Inflammatory Disease Treatment Market Size (2018-2033)
9.2 Asia Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type
9.2.1 Asia Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2018-2023)
9.2.2 Asia Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2024-2033)
9.2.3 Asia Vaginal and Vulval Inflammatory Disease Treatment Market Share by Type (2018-2033)
9.3 Asia Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application
9.3.1 Asia Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2018-2023)
9.3.2 Asia Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2024-2033)
9.3.3 Asia Vaginal and Vulval Inflammatory Disease Treatment Market Share by Application (2018-2033)
9.4 Asia Vaginal and Vulval Inflammatory Disease Treatment Market Size by Region
9.4.1 Asia Vaginal and Vulval Inflammatory Disease Treatment Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Vaginal and Vulval Inflammatory Disease Treatment Market Size by Region (2018-2023)
9.4.3 Asia Vaginal and Vulval Inflammatory Disease Treatment Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Vaginal and Vulval Inflammatory Disease Treatment Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Vaginal and Vulval Inflammatory Disease Treatment Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Vaginal and Vulval Inflammatory Disease Treatment Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Almirall
11.1.1 Almirall Company Details
11.1.2 Almirall Business Overview
11.1.3 Almirall Vaginal and Vulval Inflammatory Disease Treatment Introduction
11.1.4 Almirall Revenue in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023)
11.1.5 Almirall Recent Developments
11.2 VenusConcept
11.2.1 VenusConcept Company Details
11.2.2 VenusConcept Business Overview
11.2.3 VenusConcept Vaginal and Vulval Inflammatory Disease Treatment Introduction
11.2.4 VenusConcept Revenue in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023)
11.2.5 VenusConcept Recent Developments
11.3 ThermiGen LLC
11.3.1 ThermiGen LLC Company Details
11.3.2 ThermiGen LLC Business Overview
11.3.3 ThermiGen LLC Vaginal and Vulval Inflammatory Disease Treatment Introduction
11.3.4 ThermiGen LLC Revenue in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023)
11.3.5 ThermiGen LLC Recent Developments
11.4 Lutronic
11.4.1 Lutronic Company Details
11.4.2 Lutronic Business Overview
11.4.3 Lutronic Vaginal and Vulval Inflammatory Disease Treatment Introduction
11.4.4 Lutronic Revenue in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023)
11.4.5 Lutronic Recent Developments
11.5 BTL Group of Companies
11.5.1 BTL Group of Companies Company Details
11.5.2 BTL Group of Companies Business Overview
11.5.3 BTL Group of Companies Vaginal and Vulval Inflammatory Disease Treatment Introduction
11.5.4 BTL Group of Companies Revenue in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023)
11.5.5 BTL Group of Companies Recent Developments
11.6 Viveve
11.6.1 Viveve Company Details
11.6.2 Viveve Business Overview
11.6.3 Viveve Vaginal and Vulval Inflammatory Disease Treatment Introduction
11.6.4 Viveve Revenue in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023)
11.6.5 Viveve Recent Developments
11.7 Fotona
11.7.1 Fotona Company Details
11.7.2 Fotona Business Overview
11.7.3 Fotona Vaginal and Vulval Inflammatory Disease Treatment Introduction
11.7.4 Fotona Revenue in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023)
11.7.5 Fotona Recent Developments
11.8 Evofem Biosciences, Inc.
11.8.1 Evofem Biosciences, Inc. Company Details
11.8.2 Evofem Biosciences, Inc. Business Overview
11.8.3 Evofem Biosciences, Inc. Vaginal and Vulval Inflammatory Disease Treatment Introduction
11.8.4 Evofem Biosciences, Inc. Revenue in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023)
11.8.5 Evofem Biosciences, Inc. Recent Developments
11.9 Spero Therapeutics
11.9.1 Spero Therapeutics Company Details
11.9.2 Spero Therapeutics Business Overview
11.9.3 Spero Therapeutics Vaginal and Vulval Inflammatory Disease Treatment Introduction
11.9.4 Spero Therapeutics Revenue in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023)
11.9.5 Spero Therapeutics Recent Developments
11.10 Hologic
11.10.1 Hologic Company Details
11.10.2 Hologic Business Overview
11.10.3 Hologic Vaginal and Vulval Inflammatory Disease Treatment Introduction
11.10.4 Hologic Revenue in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023)
11.10.5 Hologic Recent Developments
11.11 Kyung Hee University Hospital
11.11.1 Kyung Hee University Hospital Company Details
11.11.2 Kyung Hee University Hospital Business Overview
11.11.3 Kyung Hee University Hospital Vaginal and Vulval Inflammatory Disease Treatment Introduction
11.11.4 Kyung Hee University Hospital Revenue in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023)
11.11.5 Kyung Hee University Hospital Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Vaginal and Vulval Inflammatory Disease Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Vaginal Dryness
Table 3. Key Players of Vaginal Burning
Table 4. Key Players of Vaginal Discharge
Table 5. Key Players of Genital Itching
Table 6. Key Players of Recurrent Urinary Tract Infections
Table 7. Key Players of Urinary Incontinence
Table 8. Key Players of Others
Table 9. Global Vaginal and Vulval Inflammatory Disease Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 10. Global Vaginal and Vulval Inflammatory Disease Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 11. Global Vaginal and Vulval Inflammatory Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global Vaginal and Vulval Inflammatory Disease Treatment Market Share by Region (2018-2023)
Table 13. Global Vaginal and Vulval Inflammatory Disease Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 14. Global Vaginal and Vulval Inflammatory Disease Treatment Market Share by Region (2024-2033)
Table 15. Vaginal and Vulval Inflammatory Disease Treatment Market Trends
Table 16. Vaginal and Vulval Inflammatory Disease Treatment Market Drivers
Table 17. Vaginal and Vulval Inflammatory Disease Treatment Market Challenges
Table 18. Vaginal and Vulval Inflammatory Disease Treatment Market Restraints
Table 19. Global Vaginal and Vulval Inflammatory Disease Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global Vaginal and Vulval Inflammatory Disease Treatment Revenue Share by Players (2018-2023)
Table 21. Global Top Vaginal and Vulval Inflammatory Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaginal and Vulval Inflammatory Disease Treatment as of 2022)
Table 22. Global Vaginal and Vulval Inflammatory Disease Treatment Industry Ranking 2021 VS 2022 VS 2023
Table 23. Global 5 Largest Players Market Share by Vaginal and Vulval Inflammatory Disease Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 24. Global Key Players of Vaginal and Vulval Inflammatory Disease Treatment, Headquarters and Area Served
Table 25. Global Key Players of Vaginal and Vulval Inflammatory Disease Treatment, Product and Application
Table 26. Global Key Players of Vaginal and Vulval Inflammatory Disease Treatment, Product and Application
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global Vaginal and Vulval Inflammatory Disease Treatment Revenue Market Share by Type (2018-2023)
Table 30. Global Vaginal and Vulval Inflammatory Disease Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 31. Global Vaginal and Vulval Inflammatory Disease Treatment Revenue Market Share by Type (2024-2033)
Table 32. Global Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global Vaginal and Vulval Inflammatory Disease Treatment Revenue Share by Application (2018-2023)
Table 34. Global Vaginal and Vulval Inflammatory Disease Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 35. Global Vaginal and Vulval Inflammatory Disease Treatment Revenue Share by Application (2024-2033)
Table 36. North America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 37. North America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 38. North America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 39. North America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 40. North America Vaginal and Vulval Inflammatory Disease Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. North America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. North America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 43. Europe Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 44. Europe Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 45. Europe Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 46. Europe Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 47. Europe Vaginal and Vulval Inflammatory Disease Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 48. Europe Vaginal and Vulval Inflammatory Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 49. Europe Vaginal and Vulval Inflammatory Disease Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 50. China Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 51. China Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 52. China Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 53. China Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 55. Asia Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 56. Asia Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 57. Asia Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 58. Asia Vaginal and Vulval Inflammatory Disease Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 59. Asia Vaginal and Vulval Inflammatory Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 60. Asia Vaginal and Vulval Inflammatory Disease Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Vaginal and Vulval Inflammatory Disease Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 66. Middle East, Africa, and Latin America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 67. Middle East, Africa, and Latin America Vaginal and Vulval Inflammatory Disease Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 68. Almirall Company Details
Table 69. Almirall Business Overview
Table 70. Almirall Vaginal and Vulval Inflammatory Disease Treatment Product
Table 71. Almirall Revenue in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023) & (US$ Million)
Table 72. Almirall Recent Developments
Table 73. VenusConcept Company Details
Table 74. VenusConcept Business Overview
Table 75. VenusConcept Vaginal and Vulval Inflammatory Disease Treatment Product
Table 76. VenusConcept Revenue in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023) & (US$ Million)
Table 77. VenusConcept Recent Developments
Table 78. ThermiGen LLC Company Details
Table 79. ThermiGen LLC Business Overview
Table 80. ThermiGen LLC Vaginal and Vulval Inflammatory Disease Treatment Product
Table 81. ThermiGen LLC Revenue in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023) & (US$ Million)
Table 82. ThermiGen LLC Recent Developments
Table 83. Lutronic Company Details
Table 84. Lutronic Business Overview
Table 85. Lutronic Vaginal and Vulval Inflammatory Disease Treatment Product
Table 86. Lutronic Revenue in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023) & (US$ Million)
Table 87. Lutronic Recent Developments
Table 88. BTL Group of Companies Company Details
Table 89. BTL Group of Companies Business Overview
Table 90. BTL Group of Companies Vaginal and Vulval Inflammatory Disease Treatment Product
Table 91. BTL Group of Companies Revenue in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023) & (US$ Million)
Table 92. BTL Group of Companies Recent Developments
Table 93. Viveve Company Details
Table 94. Viveve Business Overview
Table 95. Viveve Vaginal and Vulval Inflammatory Disease Treatment Product
Table 96. Viveve Revenue in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023) & (US$ Million)
Table 97. Viveve Recent Developments
Table 98. Fotona Company Details
Table 99. Fotona Business Overview
Table 100. Fotona Vaginal and Vulval Inflammatory Disease Treatment Product
Table 101. Fotona Revenue in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023) & (US$ Million)
Table 102. Fotona Recent Developments
Table 103. Evofem Biosciences, Inc. Company Details
Table 104. Evofem Biosciences, Inc. Business Overview
Table 105. Evofem Biosciences, Inc. Vaginal and Vulval Inflammatory Disease Treatment Product
Table 106. Evofem Biosciences, Inc. Revenue in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023) & (US$ Million)
Table 107. Evofem Biosciences, Inc. Recent Developments
Table 108. Spero Therapeutics Company Details
Table 109. Spero Therapeutics Business Overview
Table 110. Spero Therapeutics Vaginal and Vulval Inflammatory Disease Treatment Product
Table 111. Spero Therapeutics Revenue in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023) & (US$ Million)
Table 112. Spero Therapeutics Recent Developments
Table 113. Hologic Company Details
Table 114. Hologic Business Overview
Table 115. Hologic Vaginal and Vulval Inflammatory Disease Treatment Product
Table 116. Hologic Revenue in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023) & (US$ Million)
Table 117. Hologic Recent Developments
Table 118. Kyung Hee University Hospital Company Details
Table 119. Kyung Hee University Hospital Business Overview
Table 120. Kyung Hee University Hospital Vaginal and Vulval Inflammatory Disease Treatment Product
Table 121. Kyung Hee University Hospital Revenue in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023) & (US$ Million)
Table 122. Kyung Hee University Hospital Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vaginal and Vulval Inflammatory Disease Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Vaginal and Vulval Inflammatory Disease Treatment Market Share by Type: 2022 VS 2033
Figure 3. Vaginal Dryness Features
Figure 4. Vaginal Burning Features
Figure 5. Vaginal Discharge Features
Figure 6. Genital Itching Features
Figure 7. Recurrent Urinary Tract Infections Features
Figure 8. Urinary Incontinence Features
Figure 9. Others Features
Figure 10. Global Vaginal and Vulval Inflammatory Disease Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 11. Global Vaginal and Vulval Inflammatory Disease Treatment Market Share by Application: 2022 VS 2033
Figure 12. Hospital Pharmacies Case Studies
Figure 13. Specialty Clinics Case Studies
Figure 14. Others Case Studies
Figure 15. Vaginal and Vulval Inflammatory Disease Treatment Report Years Considered
Figure 16. Global Vaginal and Vulval Inflammatory Disease Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global Vaginal and Vulval Inflammatory Disease Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 18. Global Vaginal and Vulval Inflammatory Disease Treatment Market Share by Region: 2022 VS 2033
Figure 19. Global Vaginal and Vulval Inflammatory Disease Treatment Market Share by Players in 2022
Figure 20. Global Top Vaginal and Vulval Inflammatory Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaginal and Vulval Inflammatory Disease Treatment as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Vaginal and Vulval Inflammatory Disease Treatment Revenue in 2022
Figure 22. North America Vaginal and Vulval Inflammatory Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America Vaginal and Vulval Inflammatory Disease Treatment Market Share by Type (2018-2033)
Figure 24. North America Vaginal and Vulval Inflammatory Disease Treatment Market Share by Application (2018-2033)
Figure 25. North America Vaginal and Vulval Inflammatory Disease Treatment Market Share by Country (2018-2033)
Figure 26. United States Vaginal and Vulval Inflammatory Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Canada Vaginal and Vulval Inflammatory Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Europe Vaginal and Vulval Inflammatory Disease Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 29. Europe Vaginal and Vulval Inflammatory Disease Treatment Market Share by Type (2018-2033)
Figure 30. Europe Vaginal and Vulval Inflammatory Disease Treatment Market Share by Application (2018-2033)
Figure 31. Europe Vaginal and Vulval Inflammatory Disease Treatment Market Share by Country (2018-2033)
Figure 32. Germany Vaginal and Vulval Inflammatory Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. France Vaginal and Vulval Inflammatory Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. U.K. Vaginal and Vulval Inflammatory Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Italy Vaginal and Vulval Inflammatory Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Russia Vaginal and Vulval Inflammatory Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Nordic Countries Vaginal and Vulval Inflammatory Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. China Vaginal and Vulval Inflammatory Disease Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 39. China Vaginal and Vulval Inflammatory Disease Treatment Market Share by Type (2018-2033)
Figure 40. China Vaginal and Vulval Inflammatory Disease Treatment Market Share by Application (2018-2033)
Figure 41. Asia Vaginal and Vulval Inflammatory Disease Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 42. Asia Vaginal and Vulval Inflammatory Disease Treatment Market Share by Type (2018-2033)
Figure 43. Asia Vaginal and Vulval Inflammatory Disease Treatment Market Share by Application (2018-2033)
Figure 44. Asia Vaginal and Vulval Inflammatory Disease Treatment Market Share by Region (2018-2033)
Figure 45. Japan Vaginal and Vulval Inflammatory Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. South Korea Vaginal and Vulval Inflammatory Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. China Taiwan Vaginal and Vulval Inflammatory Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Southeast Asia Vaginal and Vulval Inflammatory Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. India Vaginal and Vulval Inflammatory Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Australia Vaginal and Vulval Inflammatory Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Vaginal and Vulval Inflammatory Disease Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Vaginal and Vulval Inflammatory Disease Treatment Market Share by Type (2018-2033)
Figure 53. Middle East, Africa, and Latin America Vaginal and Vulval Inflammatory Disease Treatment Market Share by Application (2018-2033)
Figure 54. Middle East, Africa, and Latin America Vaginal and Vulval Inflammatory Disease Treatment Market Share by Country (2018-2033)
Figure 55. Brazil Vaginal and Vulval Inflammatory Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Mexico Vaginal and Vulval Inflammatory Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Turkey Vaginal and Vulval Inflammatory Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Saudi Arabia Vaginal and Vulval Inflammatory Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Israel Vaginal and Vulval Inflammatory Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. GCC Countries Vaginal and Vulval Inflammatory Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 61. Almirall Revenue Growth Rate in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023)
Figure 62. VenusConcept Revenue Growth Rate in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023)
Figure 63. ThermiGen LLC Revenue Growth Rate in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023)
Figure 64. Lutronic Revenue Growth Rate in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023)
Figure 65. BTL Group of Companies Revenue Growth Rate in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023)
Figure 66. Viveve Revenue Growth Rate in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023)
Figure 67. Fotona Revenue Growth Rate in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023)
Figure 68. Evofem Biosciences, Inc. Revenue Growth Rate in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023)
Figure 69. Spero Therapeutics Revenue Growth Rate in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023)
Figure 70. Hologic Revenue Growth Rate in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023)
Figure 71. Kyung Hee University Hospital Revenue Growth Rate in Vaginal and Vulval Inflammatory Disease Treatment Business (2018-2023)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed